213 related articles for article (PubMed ID: 30801710)
1. Treatment of melanoma of unknown primary in the era of immunotherapy and targeted therapy: A Dutch population-based study.
Verver D; van der Veldt A; van Akkooi A; Verhoef C; Grünhagen DJ; Louwman WJ
Int J Cancer; 2020 Jan; 146(1):26-34. PubMed ID: 30801710
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy.
Verver D; Grünhagen DJ; van Akkooi ACJ; Aarts MJB; van den Berkmortel FWPJ; van den Eertwegh AJM; de Groot JWB; Boers-Sonderen MJ; Haanen JBAG; Hospers GAP; Kapiteijn E; Piersma D; van Rijn RS; Suijkerbuijk KPM; Tije AJT; Vreugdenhil G; Verhoef C; van der Veldt AAM
Cancer Immunol Immunother; 2021 Nov; 70(11):3123-3135. PubMed ID: 33774697
[TBL] [Abstract][Full Text] [Related]
3. Treatment Outcomes for Metastatic Melanoma of Unknown Primary in the New Era: A Single-Institution Study and Review of the Literature.
Utter K; Goldman C; Weiss SA; Shapiro RL; Berman RS; Wilson MA; Pavlick AC; Osman I
Oncology; 2017; 93(4):249-258. PubMed ID: 28746931
[TBL] [Abstract][Full Text] [Related]
4. Melanoma of unknown primary: New perspectives for an old story.
Boussios S; Rassy E; Samartzis E; Moschetta M; Sheriff M; Pérez-Fidalgo JA; Pavlidis N
Crit Rev Oncol Hematol; 2021 Feb; 158():103208. PubMed ID: 33383207
[TBL] [Abstract][Full Text] [Related]
5. Melanoma of unknown primary origin: a population-based study in the Netherlands.
de Waal AC; Aben KK; van Rossum MM; Kiemeney LA
Eur J Cancer; 2013 Feb; 49(3):676-83. PubMed ID: 23031553
[TBL] [Abstract][Full Text] [Related]
6. Improved survival for stage IV melanoma from an unknown primary site.
Lee CC; Faries MB; Wanek LA; Morton DL
J Clin Oncol; 2009 Jul; 27(21):3489-95. PubMed ID: 19451446
[TBL] [Abstract][Full Text] [Related]
7. Melanoma of Unknown Primary: Evaluation of the Characteristics, Treatment Strategies, Prognostic Factors in a Monocentric Retrospective Study.
Del Fiore P; Rastrelli M; Dall'Olmo L; Cavallin F; Cappellesso R; Vecchiato A; Buja A; Spina R; Parisi A; Mazzarotto R; Ferrazzi B; Grego A; Rotondi A; Benna C; Tropea S; Russano F; Filoni A; Bassetto F; Tos APD; Alaibac M; Rossi CR; Pigozzo J; Sileni VC; Mocellin S
Front Oncol; 2021; 11():627527. PubMed ID: 33747946
[TBL] [Abstract][Full Text] [Related]
8. Multidisciplinary Care for Melanoma of Unknown Primary: Experience in the Era of Molecular Profiling.
De Andrade JP; Wong P; O'Leary MP; Parekh V; Amini A; Schoellhammer HF; Margolin KA; Afkhami M; Melstrom LG
Ann Surg Oncol; 2020 Dec; 27(13):5240-5247. PubMed ID: 32909128
[TBL] [Abstract][Full Text] [Related]
9. Survival and therapeutic response in patients with melanoma of unknown and known primary: a single-centre retrospective analysis.
Ludwig SV; F Cheng P; Mangana J; Braun R; Dummer R; Koelblinger P
Eur J Dermatol; 2020 Dec; 30(6):699-709. PubMed ID: 33459260
[TBL] [Abstract][Full Text] [Related]
10. Brain metastases in adult patients with melanoma of unknown primary in the Netherlands (2011-2020).
Padilla CS; Ho VKY; Mooijenkind TWAN; Louwman MWJ; de Vos FYFL; Bekkenk MW; Minnaard WA; Loef C; van Zanten SEMV
J Neurooncol; 2023 May; 163(1):239-248. PubMed ID: 37169949
[TBL] [Abstract][Full Text] [Related]
11. Stage IV melanoma of unknown primary: A population-based study in the United States from 1973 to 2014.
Scott JF; Conic RZ; Thompson CL; Gerstenblith MR; Bordeaux JS
J Am Acad Dermatol; 2018 Aug; 79(2):258-265.e4. PubMed ID: 29580859
[TBL] [Abstract][Full Text] [Related]
12. Improved survival after lymphadenectomy for nodal metastasis from an unknown primary melanoma.
Lee CC; Faries MB; Wanek LA; Morton DL
J Clin Oncol; 2008 Feb; 26(4):535-41. PubMed ID: 18235114
[TBL] [Abstract][Full Text] [Related]
13. Impact of systemic therapies in metastatic melanoma of unknown primary: A study from MELBASE, a French multicentric prospective cohort.
Rousset P; Dalle S; Mortier L; Dereure O; Dalac S; Dutriaux C; Leccia MT; Legoupil D; Brunet-Possenti F; De Quatrebarbes J; Grob JJ; Saiag P; Maubec E; Stoebner PE; Granel-Brocard F; Arnault JP; Allayous C; Oriano B; Lebbe C; Montaudié H
J Am Acad Dermatol; 2023 Apr; 88(4):808-815. PubMed ID: 36543626
[TBL] [Abstract][Full Text] [Related]
14. Melanoma with unknown primary: report and analysis of 24 patients.
Clerico R; Bottoni U; Paolino G; Ambrifi M; Corsetti P; Devirgiliis V; Calvieri S
Med Oncol; 2012 Dec; 29(4):2978-84. PubMed ID: 22460835
[TBL] [Abstract][Full Text] [Related]
15. Metastatic melanoma to lymph nodes in patients with unknown primary sites.
Cormier JN; Xing Y; Feng L; Huang X; Davidson L; Gershenwald JE; Lee JE; Mansfield PF; Ross MI
Cancer; 2006 May; 106(9):2012-20. PubMed ID: 16568458
[TBL] [Abstract][Full Text] [Related]
16. Use of immunotherapy and surgery for stage IV melanoma.
Molina G; Kasumova GG; Qadan M; Boland GM
Cancer; 2020 Jun; 126(11):2614-2624. PubMed ID: 32157676
[TBL] [Abstract][Full Text] [Related]
17. Melanoma of unknown primary site: presentation, treatment, and prognosis--a single institution study. University of Pennsylvania Pigmented Lesion Study Group.
Anbari KK; Schuchter LM; Bucky LP; Mick R; Synnestvedt M; Guerry D; Hamilton R; Halpern AC
Cancer; 1997 May; 79(9):1816-21. PubMed ID: 9129001
[TBL] [Abstract][Full Text] [Related]
18. Metastatic melanoma of unknown primary resembles the genotype of cutaneous melanomas.
Egberts F; Bergner I; Krüger S; Haag J; Behrens HM; Hauschild A; Röcken C
Ann Oncol; 2014 Jan; 25(1):246-50. PubMed ID: 24276025
[TBL] [Abstract][Full Text] [Related]
19. Disease kinetics but not disease burden is relevant for survival in melanoma of unknown primary tumor.
Heppt MV; Tietze JK; Reinholz M; Rahimi F; Jung A; Kirchner T; Ruzicka T; Flaig MJ; Berking C
Discov Med; 2015 Oct; 20(110):231-7. PubMed ID: 26562476
[TBL] [Abstract][Full Text] [Related]
20. Improved prognosis and evidence of enhanced immunogenicity in tumor and circulation of high-risk melanoma patients with unknown primary.
Tarhini AA; Lee SJ; Tan AC; El Naqa IM; Stephen Hodi F; Butterfield LH; LaFramboise WA; Storkus WJ; Karunamurthy AD; Conejo-Garcia JR; Hwu P; Streicher H; Sondak VK; Kirkwood JM
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35074904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
